WallStreetZenWallStreetZen

NASDAQ: LYCA
Lycia Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Lycia Therapeutics revenue was N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LYCA annual revenue was $6.7M, with -54.9% growth year-over-year.

LYCA revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when LYCA announces revenue.

LYCA Revenue History By Year

LYCA Yearly RevenueLYCA RevenueLYCA ChangeLYCA Revenue Growth
2025-12-31$6.74M-$8.20M-54.87%
2024-12-31$14.94MN/AN/A

1 of 1

Lycia Therapeutics Revenue FAQ

What was Lycia Therapeutics's annual revenue growth in the past year?

As of Q4 2026, Lycia Therapeutics's revenue has grown null year over year. Lycia Therapeutics's revenue in the past year totaled N/A.

How much does Lycia Therapeutics make in a year?

Lycia Therapeutics's revenue by year for the past one years is:
  • Lycia Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $6.74 million, a 54.87% decrease year over year.

What was Lycia Therapeutics's revenue in 2025?

Lycia Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $6.74 million, a 54.87% decrease year over year.

How much does Lycia Therapeutics make in a day?

Based on Lycia Therapeutics annual revenue for the past one years, LYCA makes an average of $18,468.49 per day.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.